Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    - Added a government funding notice affecting page operations and status. - Updated page version from v3.1.0 to v3.2.0. - Removed a MedlinePlus Genetics topic: Melanoma.
    Difference
    3%
    Check dated 2025-10-05T14:28:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T09:46:54.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; removed the Back to Top link, a minor navigation change.
    Difference
    0.1%
    Check dated 2025-09-14T00:11:44.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Melanoma under MedlinePlus Genetics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.3%
    Check dated 2025-09-06T19:59:58.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as various scientific terms related to proteins and antibodies. Notably, the revision number has changed from v2.16.12 to v3.0.0, indicating a major update.
    Difference
    2%
    Check dated 2025-08-30T15:27:36.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T11:36:55.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.